These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9935187)

  • 1. Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation.
    Verkaik NS; Trapman J; Romijn JC; Van der Kwast TH; Van Steenbrugge GJ
    Int J Cancer; 1999 Jan; 80(3):439-43. PubMed ID: 9935187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
    Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
    Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
    Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer.
    Kito H; Suzuki H; Ichikawa T; Sekita N; Kamiya N; Akakura K; Igarashi T; Nakayama T; Watanabe M; Harigaya K; Ito H
    Prostate; 2001 Oct; 49(2):110-5. PubMed ID: 11582589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.
    Nojima D; Li LC; Dharia A; Perinchery G; Ribeiro-Filho L; Yen TS; Dahiya R
    Cancer; 2001 Oct; 92(8):2076-83. PubMed ID: 11596023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma.
    Santourlidis S; Warskulat U; Florl AR; Maas S; Pulte T; Fischer J; Müller W; Schulz WA
    Mol Carcinog; 2001 Sep; 32(1):36-43. PubMed ID: 11568974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line.
    Sato S; Yokozaki H; Yasui W; Nikai H; Tahara E
    Jpn J Cancer Res; 1999 May; 90(5):485-9. PubMed ID: 10391086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
    Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
    Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
    Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
    Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region.
    Verkaik NS; van Steenbrugge GJ; van Weerden WM; Bussemakers MJ; van der Kwast TH
    Lab Invest; 2000 Aug; 80(8):1291-8. PubMed ID: 10950120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
    Shin Y; Kim S; An W
    Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma.
    Yan P; Mühlethaler A; Bourloud KB; Beck MN; Gross N
    Genes Chromosomes Cancer; 2003 Feb; 36(2):129-38. PubMed ID: 12508241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the neutral endopeptidase gene promoter in human prostate cancers.
    Usmani BA; Shen R; Janeczko M; Papandreou CN; Lee WH; Nelson WG; Nelson JB; Nanus DM
    Clin Cancer Res; 2000 May; 6(5):1664-70. PubMed ID: 10815884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
    Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
    Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
    Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
    Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.